M Holdings Securities’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,803
Closed -$806K 229
2023
Q1
$806K Buy
+5,803
New +$781K 0.08% 184

Other funds holding AZN

M Holdings Securities's AZN Position: Q3 2024 in Review

M Holdings Securities sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 3,423 shares — an estimated $534K sold.

M Holdings Securities first reported a position in AZN in Q1 2021 and held it in 8 quarters. The position peaked at $785K in Q3 2023. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • M Holdings Securities reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
  • M Holdings Securities sold 3,423 AstraZeneca shares in Q3 2024, an estimated $534K.
  • M Holdings Securities first reported a position in AstraZeneca in Q1 2021 and held it in 8 quarters.
  • M Holdings Securities's AstraZeneca position peaked at $785K in Q3 2023.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on M Holdings Securities's 13F filing for Q3 2024, filed 12 Nov 2024.